Analysis Metabolite Name Measured Value Units CASE_CONTROL Chemotherapy Drug Race TIMEPOINT Tamoxyfen Taxane
Reversed phase NEGATIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)-1116Peak areaCase Y Exemestane White 3 Month N Y
Reversed phase NEGATIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)-1225Peak areaCase Y Exemestane White Baseline N Y
Reversed phase NEGATIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)-1477Peak areaControl Y Exemestane White Baseline N Y
Reversed phase NEGATIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)-1513Peak areaControl Y Exemestane White 3 Month N N
Reversed phase NEGATIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)-1857Peak areaControl N Letrozole White Baseline Y N
Reversed phase NEGATIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)-1862Peak areaCase N Letrozole Black 3 Month N N
Reversed phase NEGATIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)-1945Peak areaControl N Exemestane White 3 Month N N
Reversed phase NEGATIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)-2422Peak areaControl N Letrozole Black 3 Month N N
Reversed phase NEGATIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)-3979Peak areaControl N Letrozole White 3 Month Y N
Reversed phase NEGATIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)-4735Peak areaControl Y Exemestane White 3 Month Y Y
Reversed phase NEGATIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)-Peak areaCase N Exemestane Black 3 Month N N
Reversed phase NEGATIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)-Peak areaCase N Exemestane Black Baseline N N
Reversed phase NEGATIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)-Peak areaCase N Exemestane White 3 Month N N
Reversed phase NEGATIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)-Peak areaCase N Exemestane White 3 Month Y N
Reversed phase NEGATIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)-Peak areaCase N Exemestane White Baseline N N
Reversed phase NEGATIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)-Peak areaCase N Exemestane White Baseline Y N
Reversed phase NEGATIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)-Peak areaCase N Letrozole Black Baseline N N
Reversed phase NEGATIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)-Peak areaCase N Letrozole White 3 Month N N
Reversed phase NEGATIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)-Peak areaCase N Letrozole White 3 Month Y N
Reversed phase NEGATIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)-Peak areaCase N Letrozole White Baseline N N
Reversed phase NEGATIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)-Peak areaCase N Letrozole White Baseline Y N
Reversed phase NEGATIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)-Peak areaCase Y Exemestane Black 3 Month N Y
Reversed phase NEGATIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)-Peak areaCase Y Exemestane Black Baseline N Y
Reversed phase NEGATIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)-Peak areaCase Y Exemestane White 3 Month N Y
Reversed phase NEGATIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)-Peak areaCase Y Exemestane White 3 Month Y N
Reversed phase NEGATIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)-Peak areaCase Y Exemestane White 3 Month Y Y
Reversed phase NEGATIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)-Peak areaCase Y Exemestane White Baseline N Y
Reversed phase NEGATIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)-Peak areaCase Y Exemestane White Baseline Y N
Reversed phase NEGATIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)-Peak areaCase Y Exemestane White Baseline Y Y
Reversed phase NEGATIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)-Peak areaCase Y Letrozole White 3 Month Y Y
Reversed phase NEGATIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)-Peak areaCase Y Letrozole White Baseline Y Y
Reversed phase NEGATIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)-Peak areaControl N Exemestane Black 3 Month Y N
Reversed phase NEGATIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)-Peak areaControl N Exemestane Black Baseline Y N
Reversed phase NEGATIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)-Peak areaControl N Exemestane White 3 Month N N
Reversed phase NEGATIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)-Peak areaControl N Exemestane White 3 Month Y N
Reversed phase NEGATIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)-Peak areaControl N Exemestane White Baseline N N
Reversed phase NEGATIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)-Peak areaControl N Exemestane White Baseline Y N
Reversed phase NEGATIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)-Peak areaControl N Letrozole Black Baseline N N
Reversed phase NEGATIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)-Peak areaControl N Letrozole White 3 Month N N
Reversed phase NEGATIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)-Peak areaControl N Letrozole White 3 Month Y N
Reversed phase NEGATIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)-Peak areaControl N Letrozole White Baseline N N
Reversed phase NEGATIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)-Peak areaControl N Letrozole White Baseline Y N
Reversed phase NEGATIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)-Peak areaControl Y Exemestane White 3 Month N N
Reversed phase NEGATIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)-Peak areaControl Y Exemestane White 3 Month N Y
Reversed phase NEGATIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)-Peak areaControl Y Exemestane White 3 Month Y N
Reversed phase NEGATIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)-Peak areaControl Y Exemestane White Baseline N N
Reversed phase NEGATIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)-Peak areaControl Y Exemestane White Baseline N Y
Reversed phase NEGATIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)-Peak areaControl Y Exemestane White Baseline Y N
Reversed phase NEGATIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)-Peak areaControl Y Exemestane White Baseline Y Y
Reversed phase NEGATIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)-Peak areaControl Y Letrozole White 3 Month Y N
Reversed phase NEGATIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)-Peak areaControl Y Letrozole White 3 Month Y Y
Reversed phase NEGATIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)-Peak areaControl Y Letrozole White Baseline Y N
Reversed phase NEGATIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)-Peak areaControl Y Letrozole White Baseline Y Y
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+H)+[-H2O]2566Peak areaControl N Exemestane Black 3 Month Y N
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+H)+[-H2O]Peak areaCase N Exemestane Black 3 Month N N
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+H)+[-H2O]Peak areaCase N Exemestane Black Baseline N N
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+H)+[-H2O]Peak areaCase N Exemestane White 3 Month N N
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+H)+[-H2O]Peak areaCase N Exemestane White 3 Month Y N
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+H)+[-H2O]Peak areaCase N Exemestane White Baseline N N
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+H)+[-H2O]Peak areaCase N Exemestane White Baseline Y N
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+H)+[-H2O]Peak areaCase N Letrozole Black 3 Month N N
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+H)+[-H2O]Peak areaCase N Letrozole Black Baseline N N
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+H)+[-H2O]Peak areaCase N Letrozole White 3 Month N N
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+H)+[-H2O]Peak areaCase N Letrozole White 3 Month Y N
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+H)+[-H2O]Peak areaCase N Letrozole White Baseline N N
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+H)+[-H2O]Peak areaCase N Letrozole White Baseline Y N
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+H)+[-H2O]Peak areaCase Y Exemestane Black 3 Month N Y
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+H)+[-H2O]Peak areaCase Y Exemestane Black Baseline N Y
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+H)+[-H2O]Peak areaCase Y Exemestane White 3 Month N Y
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+H)+[-H2O]Peak areaCase Y Exemestane White 3 Month Y N
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+H)+[-H2O]Peak areaCase Y Exemestane White 3 Month Y Y
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+H)+[-H2O]Peak areaCase Y Exemestane White Baseline N Y
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+H)+[-H2O]Peak areaCase Y Exemestane White Baseline Y N
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+H)+[-H2O]Peak areaCase Y Exemestane White Baseline Y Y
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+H)+[-H2O]Peak areaCase Y Letrozole White 3 Month Y Y
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+H)+[-H2O]Peak areaCase Y Letrozole White Baseline Y Y
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+H)+[-H2O]Peak areaControl N Exemestane Black Baseline Y N
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+H)+[-H2O]Peak areaControl N Exemestane White 3 Month N N
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+H)+[-H2O]Peak areaControl N Exemestane White 3 Month Y N
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+H)+[-H2O]Peak areaControl N Exemestane White Baseline N N
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+H)+[-H2O]Peak areaControl N Exemestane White Baseline Y N
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+H)+[-H2O]Peak areaControl N Letrozole Black 3 Month N N
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+H)+[-H2O]Peak areaControl N Letrozole Black Baseline N N
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+H)+[-H2O]Peak areaControl N Letrozole White 3 Month N N
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+H)+[-H2O]Peak areaControl N Letrozole White 3 Month Y N
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+H)+[-H2O]Peak areaControl N Letrozole White Baseline N N
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+H)+[-H2O]Peak areaControl N Letrozole White Baseline Y N
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+H)+[-H2O]Peak areaControl Y Exemestane White 3 Month N N
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+H)+[-H2O]Peak areaControl Y Exemestane White 3 Month N Y
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+H)+[-H2O]Peak areaControl Y Exemestane White 3 Month Y N
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+H)+[-H2O]Peak areaControl Y Exemestane White 3 Month Y Y
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+H)+[-H2O]Peak areaControl Y Exemestane White Baseline N N
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+H)+[-H2O]Peak areaControl Y Exemestane White Baseline N Y
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+H)+[-H2O]Peak areaControl Y Exemestane White Baseline Y N
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+H)+[-H2O]Peak areaControl Y Exemestane White Baseline Y Y
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+H)+[-H2O]Peak areaControl Y Letrozole White 3 Month Y N
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+H)+[-H2O]Peak areaControl Y Letrozole White 3 Month Y Y
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+H)+[-H2O]Peak areaControl Y Letrozole White Baseline Y N
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+H)+[-H2O]Peak areaControl Y Letrozole White Baseline Y Y
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+NA)+1291Peak areaCase N Exemestane White Baseline N N
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+NA)+1363Peak areaCase Y Exemestane Black Baseline N Y
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+NA)+1366Peak areaControl Y Exemestane White 3 Month Y N
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+NA)+1684Peak areaControl Y Letrozole White 3 Month Y Y
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+NA)+1855Peak areaControl N Letrozole White Baseline N N
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+NA)+2034Peak areaControl N Exemestane White 3 Month N N
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+NA)+2145Peak areaControl Y Exemestane White Baseline N Y
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+NA)+2271Peak areaControl Y Exemestane White 3 Month N Y
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+NA)+2322Peak areaControl N Exemestane White 3 Month N N
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+NA)+2428Peak areaControl N Exemestane White Baseline N N
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+NA)+2571Peak areaCase N Exemestane White 3 Month Y N
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+NA)+2798Peak areaCase N Letrozole White Baseline N N
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+NA)+3168Peak areaCase Y Exemestane White 3 Month N Y
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+NA)+3294Peak areaCase N Letrozole White Baseline Y N
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+NA)+3445Peak areaCase Y Exemestane White Baseline N Y
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+NA)+3486Peak areaCase Y Letrozole White Baseline Y Y
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+NA)+3527Peak areaControl N Letrozole White 3 Month N N
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+NA)+3813Peak areaCase N Letrozole White 3 Month Y N
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+NA)+4014Peak areaControl N Exemestane Black 3 Month Y N
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+NA)+4503Peak areaControl N Exemestane White 3 Month N N
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+NA)+4702Peak areaCase Y Exemestane White 3 Month N Y
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+NA)+Peak areaCase N Exemestane Black 3 Month N N
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+NA)+Peak areaCase N Exemestane Black Baseline N N
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+NA)+Peak areaCase N Exemestane White 3 Month N N
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+NA)+Peak areaCase N Exemestane White 3 Month Y N
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+NA)+Peak areaCase N Exemestane White Baseline N N
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+NA)+Peak areaCase N Exemestane White Baseline Y N
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+NA)+Peak areaCase N Letrozole Black 3 Month N N
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+NA)+Peak areaCase N Letrozole Black Baseline N N
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+NA)+Peak areaCase N Letrozole White 3 Month N N
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+NA)+Peak areaCase N Letrozole White 3 Month Y N
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+NA)+Peak areaCase N Letrozole White Baseline N N
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+NA)+Peak areaCase N Letrozole White Baseline Y N
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+NA)+Peak areaCase Y Exemestane Black 3 Month N Y
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+NA)+Peak areaCase Y Exemestane White 3 Month N Y
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+NA)+Peak areaCase Y Exemestane White 3 Month Y N
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+NA)+Peak areaCase Y Exemestane White 3 Month Y Y
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+NA)+Peak areaCase Y Exemestane White Baseline N Y
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+NA)+Peak areaCase Y Exemestane White Baseline Y N
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+NA)+Peak areaCase Y Exemestane White Baseline Y Y
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+NA)+Peak areaCase Y Letrozole White 3 Month Y Y
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+NA)+Peak areaCase Y Letrozole White Baseline Y Y
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+NA)+Peak areaControl N Exemestane Black Baseline Y N
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+NA)+Peak areaControl N Exemestane White 3 Month N N
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+NA)+Peak areaControl N Exemestane White 3 Month Y N
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+NA)+Peak areaControl N Exemestane White Baseline N N
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+NA)+Peak areaControl N Exemestane White Baseline Y N
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+NA)+Peak areaControl N Letrozole Black 3 Month N N
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+NA)+Peak areaControl N Letrozole Black Baseline N N
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+NA)+Peak areaControl N Letrozole White 3 Month N N
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+NA)+Peak areaControl N Letrozole White 3 Month Y N
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+NA)+Peak areaControl N Letrozole White Baseline N N
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+NA)+Peak areaControl N Letrozole White Baseline Y N
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+NA)+Peak areaControl Y Exemestane White 3 Month N N
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+NA)+Peak areaControl Y Exemestane White 3 Month N Y
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+NA)+Peak areaControl Y Exemestane White 3 Month Y N
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+NA)+Peak areaControl Y Exemestane White 3 Month Y Y
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+NA)+Peak areaControl Y Exemestane White Baseline N N
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+NA)+Peak areaControl Y Exemestane White Baseline N Y
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+NA)+Peak areaControl Y Exemestane White Baseline Y N
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+NA)+Peak areaControl Y Exemestane White Baseline Y Y
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+NA)+Peak areaControl Y Letrozole White 3 Month Y N
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+NA)+Peak areaControl Y Letrozole White 3 Month Y Y
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+NA)+Peak areaControl Y Letrozole White Baseline Y N
Reversed phase POSITIVE ION MODEN-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M+NA)+Peak areaControl Y Letrozole White Baseline Y Y

Return to search page
  logo